Inflection Point Acquisition Corp. (
NASDAQ:IPAX -
Get Free Report) shares traded up 1.1% during trading on Monday . The stock traded as high as $9.20 and last traded at $9.09. 12,492,372 shares were traded during trading, an increase of 4,398% from the average session volume of 277,739 shares. The stock had previously closed at $8.99.
Inflection Point Acquisition Trading Up 1.1%
The firm's fifty day simple moving average is $10.99 and its 200 day simple moving average is $11.18.
About Inflection Point Acquisition
(
Get Free Report)
Inflection Point Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the consumer and technology industries. The company was incorporated in 2021 and is based in New York, New York.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Inflection Point Acquisition, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Inflection Point Acquisition wasn't on the list.
While Inflection Point Acquisition currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.